We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $786B
1-Year Est. Return 40.34%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-3.64%
1 Year Est. Return
+40.34%
3 Year Est. Return
+112.81%
5 Year Est. Return
+128.34%
10 Year Est. Return
+452.52%
AUM
$300B
AUM Growth
-$49.2B
Cap. Flow
-$29.5B
Cap. Flow %
-9.85%
Top 10 Hldgs %
13.34%
Holding
11,668
New
1,181
Increased
3,621
Reduced
5,174
Closed
1,161

Sector Composition

Rank Sector Weight
1 Technology 13.08%
2 Financials 7.21%
3 Healthcare 6.43%
4 Consumer Discretionary 5.55%
5 Industrials 4.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRUS
5926
DELISTED
Merus
MRUS
$99K ﹤0.01%
3,732
+2,745
+278% +$73.6K
TQQQ icon
5927
ProShares UltraPro QQQ
TQQQ
$38.5B
$99K ﹤0.01%
3,408
-2,680
-44% -$77K
CBAY
5928
DELISTED
Cymabay Therapeutics
CBAY
$99K ﹤0.01%
31,459
-25,683
-45% -$80.8K
CRXT
5929
DELISTED
Clarus Therapeutics Holdings, Inc. Common Stock
CRXT
$99K ﹤0.01%
66,537
+20,906
+46% +$26.6K
ATAI icon
5930
AtaiBeckley Inc
ATAI
$2.69B
$98K ﹤0.01%
19,198
-530
-3% -$2.95K
BKIE icon
5931
BNY Mellon International Equity ETF
BKIE
$1.35B
$98K ﹤0.01%
4,179
+4,005
+2,302% +$94.8K
DYN icon
5932
Dyne Therapeutics
DYN
$4.8B
$98K ﹤0.01%
10,172
+9,760
+2,369% +$83.1K
GHYB icon
5933
Goldman Sachs Access High Yield Corporate Bond ETF
GHYB
$134M
$98K ﹤0.01%
2,086
+344
+20% +$16.4K
GKOS icon
5934
Glaukos
GKOS
$10.9B
$98K ﹤0.01%
1,697
-12,052
-88% -$638K
IAF
5935
abrdn Australia Equity Fund
IAF
$126M
$98K ﹤0.01%
5,196
-1,016
-16% -$17.6K
IDT icon
5936
IDT Corp
IDT
$1.66B
$98K ﹤0.01%
2,847
-5,054
-64% -$188K
OILU icon
5937
MicroSectors Oil & Gas Exp. & Prod. 3x Leveraged ETN
OILU
$74.3M
$98K ﹤0.01%
1,847
-261
-12% -$10.3K
SFST icon
5938
Southern First Bancshares
SFST
$608M
$98K ﹤0.01%
1,914
-1,706
-47% -$97.9K
UPWK icon
5939
Upwork
UPWK
$1.06B
$98K ﹤0.01%
4,216
-20,540
-83% -$514K
VLT icon
5940
Invesco High Income Trust II
VLT
$66M
$98K ﹤0.01%
8,010
+1,974
+33% +$25.9K
VSTM icon
5941
Verastem
VSTM
$596M
$98K ﹤0.01%
5,815
-39,846
-87% -$686K
NFYS.U
5942
DELISTED
Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
NFYS.U
$98K ﹤0.01%
10,000
+7,058
+240% +$69.7K
CCVI
5943
DELISTED
Churchill Capital Corp VI
CCVI
$98K ﹤0.01%
9,974
+8,181
+456% +$79.9K
RXRAU
5944
DELISTED
RXR Acquisition Corp. Units
RXRAU
$98K ﹤0.01%
10,000
+1,200
+14% +$11.8K
BBUC
5945
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$6.03B
$97K ﹤0.01%
+2,966
New +$93.1K
HROW icon
5946
Harrow
HROW
$1.5B
$97K ﹤0.01%
14,202
-829
-6% -$6.4K
PTVE
5947
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$97K ﹤0.01%
9,636
-8,844
-48% -$94.1K
DTOCU
5948
DELISTED
Digital Transformation Opportunities Corp. Units
DTOCU
$97K ﹤0.01%
9,862
+5,555
+129% +$54.6K
IBTB
5949
DELISTED
iShares iBonds Dec 2022 Term Treasury ETF
IBTB
$97K ﹤0.01%
3,836
+3,763
+5,155% +$95.4K
CRON
5950
Cronos Group
CRON
$1.16B
$96K ﹤0.01%
24,741
-5,069
-17% -$18.5K

Similar funds

UBS Group's Q1 2022 Portfolio in Review

As of Q1 2022, UBS Group held 11,668 positions worth $300B, down 14% from $349B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group withdrew a net $29.5B in Q1 2022, closing 1,161 positions and reducing 5,174 holdings. Its most notable exit was Xilinx Inc, an estimated $186M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS Group opened a new position in Shell worth $66.6M.

  • UBS Group's largest Q1 2022 buy was Shell: 1,213,213 shares worth $66.6M.
  • UBS Group added most to Tesla in Q1 2022, an estimated $388M increase.
  • UBS Group's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $911M.
  • UBS Group fully exited Xilinx Inc in Q1 2022, selling an estimated $186M.
  • UBS Group's ten largest holdings make up 13% of its $300B portfolio in Q1 2022.
  • UBS Group opened 1,181 new positions and closed 1,161 in Q1 2022.
  • UBS Group's portfolio value fell 14% quarter-over-quarter to $300B.

Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.